TY - JOUR
T1 - Factors Associated with Symptoms of Depression among People with Obesity
T2 - Analysis of a 3-Year-Peruvian National Survey
AU - Vera-Ponce, Víctor Juan
AU - Torres-Malca, Jenny Raquel
AU - Ramos, Willy
AU - Espinoza Rojas, Rubén
AU - Guerra Valencia, Jamee
AU - Loayza-Castro, Joan A.
AU - Zuzunaga-Montoya, Fiorella E.
AU - Zeñas-Trujillo, Gianella Zulema
AU - Cruz-Ausejo, Liliana
AU - De La Cruz-Vargas, Jhony A.
N1 - Publisher Copyright:
© 2023 by the authors.
PY - 2023/2
Y1 - 2023/2
N2 - Introduction: Obesity and depression contribute to the global burden of economic cost, morbidity, and mortality. Nevertheless, not all people with obesity develop depression. Objective: To determine the factors associated with depressive symptoms among people aged 15 or older with obesity from the National Demographic and Family Health Survey (ENDES in Spanish 2019–2021). Methods: Cross-sectional analytical study. The outcome of interest was the presence of depressive symptoms, assessed using the Patient Health Questionnaire-9 (PHQ-9). Crude (cPR) and adjusted (aPR) prevalence ratios were estimated using GLM Poisson distribution with robust variance estimates. Results: The prevalence of depression symptoms was 6.97%. In the multivariate analysis, a statistically significant association was found between depressive symptoms and female sex (PRa: 2.59; 95% CI 1.95–3.43); mountain region (PRa: 1.51; 95% CI 1.18–1.92); wealth index poor (PRa: 1.37; 95% CI 1.05–1.79, medium (PRa: 1.49; 95% CI 1.11–2.02), and rich (PRa: 1.65; 95% CI 1.21–2.26); daily tobacco use (PRa: 2.05, 95% CI 1.09–3.87); physical disability (PRa: 1.96, 95% CI 1.07–3.57); and a history of arterial hypertension (PRa: 2.05; 95% CI 1.63–2.55). Conclusion: There are several sociodemographic factors (such as being female and living in the Andean region) and individual factors (daily use of tobacco and history of hypertension) associated with depressive symptoms in Peruvian inhabitants aged 15 or older with obesity. In this study, the COVID-19 pandemic was associated with an increase in depressive symptoms.
AB - Introduction: Obesity and depression contribute to the global burden of economic cost, morbidity, and mortality. Nevertheless, not all people with obesity develop depression. Objective: To determine the factors associated with depressive symptoms among people aged 15 or older with obesity from the National Demographic and Family Health Survey (ENDES in Spanish 2019–2021). Methods: Cross-sectional analytical study. The outcome of interest was the presence of depressive symptoms, assessed using the Patient Health Questionnaire-9 (PHQ-9). Crude (cPR) and adjusted (aPR) prevalence ratios were estimated using GLM Poisson distribution with robust variance estimates. Results: The prevalence of depression symptoms was 6.97%. In the multivariate analysis, a statistically significant association was found between depressive symptoms and female sex (PRa: 2.59; 95% CI 1.95–3.43); mountain region (PRa: 1.51; 95% CI 1.18–1.92); wealth index poor (PRa: 1.37; 95% CI 1.05–1.79, medium (PRa: 1.49; 95% CI 1.11–2.02), and rich (PRa: 1.65; 95% CI 1.21–2.26); daily tobacco use (PRa: 2.05, 95% CI 1.09–3.87); physical disability (PRa: 1.96, 95% CI 1.07–3.57); and a history of arterial hypertension (PRa: 2.05; 95% CI 1.63–2.55). Conclusion: There are several sociodemographic factors (such as being female and living in the Andean region) and individual factors (daily use of tobacco and history of hypertension) associated with depressive symptoms in Peruvian inhabitants aged 15 or older with obesity. In this study, the COVID-19 pandemic was associated with an increase in depressive symptoms.
KW - association
KW - depression
KW - epidemiologic factors
KW - obesity
UR - http://www.scopus.com/inward/record.url?scp=85147818128&partnerID=8YFLogxK
U2 - 10.3390/ijerph20031816
DO - 10.3390/ijerph20031816
M3 - Original Article
C2 - 36767183
AN - SCOPUS:85147818128
SN - 1661-7827
VL - 20
JO - International Journal of Environmental Research and Public Health
JF - International Journal of Environmental Research and Public Health
IS - 3
M1 - 1816
ER -
